Tweet
Did you ever get in a fight when you were all hammer head sharked and some guy who you thought you could handle easily did a tap dance on your face? Well that never happened to $$$MR. MARKET$$$. Usually when some guy’s girlfriend was drooling all over me and he got all faceful, he’d take her to another joint. However, I have seen some guys come in on Monday morning after a rough weekend with Band-Aids all over their face. I bet they would be happy if there was a way for them to get the crap beat out of them but not have to wear Band-Aids. Well… there is!
Today I bought CLSR (Closure Medical) at 30.45. I will sell it in 4 to 6 weeks at 35.14. Here’s why I like CLSR:
CLSR’s stock is up 279% off of its 52 week low. The R^2 for this price climb is 0.84 which illustrates very strong and sustained price momentum.
Liquiderm is applied by squeezing drops from a small plastic bottle onto a sponge-tipped swab and rolling the sponge over scrapes or cuts. Within seconds, the liquid turns into a plastic film. Instant Band-aid. Another big advantage is that it's really good at stopping bleeding much faster than a bandage. Since the Liquiderm eventually wears off by itself, you never have to worry about kids crying after you rip the Bandaid off with the hair and scab still firmly attached.
Closure has a history of signing deals with big names. A unit of Colgate Palmolive Co. partners with Closure on Soothe-N-Seal, its canker sore sealant. Now they have J&J in their pocket. Big names for big buckaroos.
Closure’s lead product, a surgical glue called Dermabond is designed to replace up to 30% of all operating room sutures. Not every physician has the ability to turn a sow's ear into a silk purse. Now instead of Babar the clumsy suturing your beloved first born after they slip in the tub and split their chin, Babar can use a ProPen to strategically deliver the space-age surgical glue Dermabond to fix up little Johnny. Better yet nurses can also use the product freeing the doctor to better spend his time checking the sports page, playing golf or getting a S & T. Dermabond can be applied in one-third the time it takes doctors to stitch an incision closed. You basically just paint it on so it doesn’t hurt to be applied or removed. No more crying patients. Dermabond sloughs off naturally in about five to 10 days. That eliminates the need for a return trip to the doctor to have sutures removed.
All of this stuff sounds great in theory but will the customer buy it? They sure will. Sales have been growing by 25% per year for the last 4 years. $$$MR. MARKET$$$ believe sales will pass $35 million for 2003 which should get earnings of $0.55 share. Even the wimps at First Call think CLSR will make $0.65 in 2004. This modest prediction will get the stock price to 38.
While the P/E for CLSR is kind of pricey, you have to remember you are looking at a brand new product which is just starting to get acceptance. How many people do you know had a DVD player 3 years ago? CLSR has been solidly profitable for over 3 years now. They have moved their company into the realm of self-fueled growth capability.
Feeling a little nervous? Here’s what the boss had to say about their most recent quarterly performance: “Obviously we are pleased with the momentum in our business and the growth realized for the quarter as well as year-to-date. CLOSURE's unprecedented performance derives not only from our own internal initiatives, but also from those of our partners at Johnson & Johnson. By the beginning of next year, we plan to introduce new line extensions to complement current products which we believe will drive future growth." Wow! More fun products to make more monies. As CLSR increases their sales, they improve their gross margins via volume efficiencies.
Investors looking for a value play really shouldn’t be looking at CLSR. Anyone buying this stock is buying this idea. The good news is that this idea is being accepted.
So go ahead and drink 1000 beers and go pinch some chick’s butt this weekend. No matter what happens, you won’t have to go to work Monday with Band-Aids on your face.
Today I bought CLSR (Closure Medical) at 30.45. I will sell it in 4 to 6 weeks at 35.14. Here’s why I like CLSR:
CLSR’s stock is up 279% off of its 52 week low. The R^2 for this price climb is 0.84 which illustrates very strong and sustained price momentum.
Liquiderm is applied by squeezing drops from a small plastic bottle onto a sponge-tipped swab and rolling the sponge over scrapes or cuts. Within seconds, the liquid turns into a plastic film. Instant Band-aid. Another big advantage is that it's really good at stopping bleeding much faster than a bandage. Since the Liquiderm eventually wears off by itself, you never have to worry about kids crying after you rip the Bandaid off with the hair and scab still firmly attached.
Closure has a history of signing deals with big names. A unit of Colgate Palmolive Co. partners with Closure on Soothe-N-Seal, its canker sore sealant. Now they have J&J in their pocket. Big names for big buckaroos.
Closure’s lead product, a surgical glue called Dermabond is designed to replace up to 30% of all operating room sutures. Not every physician has the ability to turn a sow's ear into a silk purse. Now instead of Babar the clumsy suturing your beloved first born after they slip in the tub and split their chin, Babar can use a ProPen to strategically deliver the space-age surgical glue Dermabond to fix up little Johnny. Better yet nurses can also use the product freeing the doctor to better spend his time checking the sports page, playing golf or getting a S & T. Dermabond can be applied in one-third the time it takes doctors to stitch an incision closed. You basically just paint it on so it doesn’t hurt to be applied or removed. No more crying patients. Dermabond sloughs off naturally in about five to 10 days. That eliminates the need for a return trip to the doctor to have sutures removed.
All of this stuff sounds great in theory but will the customer buy it? They sure will. Sales have been growing by 25% per year for the last 4 years. $$$MR. MARKET$$$ believe sales will pass $35 million for 2003 which should get earnings of $0.55 share. Even the wimps at First Call think CLSR will make $0.65 in 2004. This modest prediction will get the stock price to 38.
While the P/E for CLSR is kind of pricey, you have to remember you are looking at a brand new product which is just starting to get acceptance. How many people do you know had a DVD player 3 years ago? CLSR has been solidly profitable for over 3 years now. They have moved their company into the realm of self-fueled growth capability.
Feeling a little nervous? Here’s what the boss had to say about their most recent quarterly performance: “Obviously we are pleased with the momentum in our business and the growth realized for the quarter as well as year-to-date. CLOSURE's unprecedented performance derives not only from our own internal initiatives, but also from those of our partners at Johnson & Johnson. By the beginning of next year, we plan to introduce new line extensions to complement current products which we believe will drive future growth." Wow! More fun products to make more monies. As CLSR increases their sales, they improve their gross margins via volume efficiencies.
Investors looking for a value play really shouldn’t be looking at CLSR. Anyone buying this stock is buying this idea. The good news is that this idea is being accepted.
So go ahead and drink 1000 beers and go pinch some chick’s butt this weekend. No matter what happens, you won’t have to go to work Monday with Band-Aids on your face.
Comment